SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-18-027821
Filing Date
2018-04-27
Accepted
2018-04-27 16:41:42
Documents
5
Effectiveness Date
2018-04-27

Document Format Files

Seq Description Document Type Size
1 DEFA14A a18-3094_3defa14a.htm DEFA14A 32255
2 GRAPHIC g30943bci001.gif GRAPHIC 91545
3 GRAPHIC g30943bci002.gif GRAPHIC 153811
4 GRAPHIC g30943bci003.gif GRAPHIC 52592
5 GRAPHIC g30943bci004.gif GRAPHIC 4709
  Complete submission text file 0001104659-18-027821.txt   450432
Mailing Address 87 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 (617) 401-4060
Ra Pharmaceuticals, Inc. (Filer) CIK: 0001481512 (see all company filings)

IRS No.: 262908274 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37926 | Film No.: 18784684
SIC: 2834 Pharmaceutical Preparations